Exclusive

Publication

Byline

Singapore-based startup Aevice Health announces expansion into Australian market

Singapore, Dec. 23 -- AeviceMD Monitoring System, a non-invasive wearable respiratory monitoring solution developed by Singapore-based Aevice Health, has been included in the Australian Register of Th... Read More


Asahi Kasei Pharma to relocate global R&D hub to Shonan iPark in Japan

Singapore, Dec. 23 -- Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture (Ohito) to Shonan Health Innovation Park (Shonan iPark) in Jan... Read More


Korea to build collaborative clinical sample analysis network for pandemic response

Singapore, Dec. 23 -- The International Vaccine Institute (IVI) and the Korea Disease Control and Prevention Agency (KDCA), together with four partner institutions, have signed a Memorandum of Underst... Read More


Japan's Chitose and Fujifilm Biosciences partner to drive global innovation and biopharma manufacturing

Singapore, Dec. 22 -- Japan-based Chitose Laboratory Corp. and Fujifilm Biosciences Inc. have announced a new strategic alliance that leverages the strengths of both companies in advancing biopharmace... Read More


Korea's Samsung Biologics expands US manufacturing capabilities after acquiring Human Genome Sciences from GSK

Singapore, Dec. 22 -- South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has announced that its wholly owned US subsidiary, Samsung Biologics Am... Read More


Australia develops new antimalarial drug candidate to address growing challenge of drug resistance

Singapore, Dec. 22 -- Researchers in Australia have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce malaria transmission... Read More


China's Jacobio inks immuno-oncology deal worth $1.9 B with AstraZeneca

Singapore, Dec. 22 -- China-based Jacobio Pharma has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73.AstraZeneca will receive exclusive development and commercia... Read More


Dubai's Mohammed Bin Rashid University of Medicine and Health Sciences introduces new nursing education programmes

Singapore, Dec. 22 -- Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the learning and discovery arm of Dubai Health, has introduced new nursing education programmes through the... Read More


Japan's Meiji Seika Pharma collaborates with MBC BioLabs for global innovation in drug discovery

Singapore, Dec. 19 -- Japan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs which is a private organisation supporting the development of biotech startup companies i... Read More


Harbour BioMed, Bristol Myers Squibb strike $1B multi-specific antibody deal

Singapore, Dec. 19 -- China and US based HarbourBioMed has announced a multi-year, global strategic collaboration and license agreement with Bristol Myers Squibb to discover and develop next-generatio... Read More